Always contact the Pulmonary Research Pager at 5-9285 for questions and enrollment The following is a list of Clinical Trials currently being conducted in the Division of Pulmonary and Critical Care Medicine. Please click on the study name for more information. To search the Clinical Trials by indication, click here. Study Name | PI | Chiron Study TFP008 A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-blind, Three-Arm Study to Evaluate the Safety and Efficacy of Tifacogin [Recombinant Tissue Factor Pathway Inhibitor] Administration in Subjects with Severe Community-Acquired Pneumonia | Jane Dematte, MD | Mediators of Myofibroblast Differentiation in ARDS | Manu Jain, MD | The Role of Endothelial Apoptosis in Sepsis | Manu Jain, MD | The Study of Acid Reflux and Asthma (SARA) | Lewis Smith, MD | | A Double-Blind Placebo-controlled Efficacy and Sarety Study of RO3300074 (5 mg/day) in the Treatment of Moderate-Severe COPD with Emphysema | Peter Sporn, MD | | Immunomodulatory Responses to Antibiotics and Herbal Medicines:A Pharmacogenomic Analysis | Richard Wunderink, MD | | Efficacy of Macrolide Immunomodulation in Severe Sepsis | Richard Wunderink, MD | | A randomized, double-blind, placebo-controlled, phase-2B study to assess the safety and efficacy effects of ART-123 on subjects with sepsis and disseminated intravascular coagulation. | Richard Wunderink, MD | A Placebo-controlled, Double-blind, Dose-escalation Study to assess the safety, tolerability, and pharmacokinetics and pharmacodynamics of single and multiple intravenous infusions of CytoFab TM (AZD9773) in Patients with Severe Sepsis | Richard Wunderink, MD |
|
